微小RNA在胰腺癌中的作用
The Role of microRNA in Pancreatic Cancer.
作者信息
Smolarz Beata, Durczyński Adam, Romanowicz Hanna, Hogendorf Piotr
机构信息
Laboratory of Cancer Genetics, Department of Pathology, Polish Mother's Memorial Hospital Research Institute, 93-338 Lodz, Poland.
Department of General and Transplant Surgery, N. Barlicki Memorial Clinical Hospital, Medical University of Lodz, 90-153 Lodz, Poland.
出版信息
Biomedicines. 2021 Sep 26;9(10):1322. doi: 10.3390/biomedicines9101322.
Abstract
MicroRNAs (miRNAs) are small ribonucleic acid molecules that play a key role in regulating gene expression. The increasing number of studies undertaken on the functioning of microRNAs in the tumor formation clearly indicates their important potential in oncological therapy. Pancreatic cancer is one of the deadliest cancers. The expression of miRNAs released into the bloodstream appears to be a good indicator of progression and evaluation of the aggressiveness of pancreatic cancer, as indicated by studies. The work reviewed the latest literature on the importance of miRNAs for pancreatic cancer development.
摘要
微小RNA（miRNA）是一类小核糖核酸分子，在调节基因表达中起关键作用。对微小RNA在肿瘤形成过程中功能的研究越来越多，这清楚地表明了它们在肿瘤治疗中的重要潜力。胰腺癌是最致命的癌症之一。研究表明，释放到血液中的miRNA的表达似乎是胰腺癌进展和侵袭性评估的良好指标。这项工作回顾了关于miRNA对胰腺癌发展重要性的最新文献。
相似文献
1
The Role of microRNA in Pancreatic Cancer.
Biomedicines. 2021 Sep 26;9(10):1322. doi: 10.3390/biomedicines9101322.
2
MicroRNAs in Hepatobiliary and Pancreatic Cancers.
Front Genet. 2011 Sep 16;2:66. doi: 10.3389/fgene.2011.00066. eCollection 2011.
3
Clinical value of circular RNAs and autophagy-related miRNAs in the diagnosis and treatment of pancreatic cancer.
Hepatobiliary Pancreat Dis Int. 2019 Dec;18(6):511-516. doi: 10.1016/j.hbpd.2019.09.009. Epub 2019 Sep 28.
4
The Role of miRNAs in the Regulation of Pancreatic Cancer Stem Cells.
Stem Cells Int. 2016;2016:8352684. doi: 10.1155/2016/8352684. Epub 2016 Feb 24.
5
miRNA and cancer; computational and experimental approaches.
Curr Pharm Biotechnol. 2014;15(5):429. doi: 10.2174/138920101505140828161335.
6
MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer.
Int J Biol Sci. 2016 Jan 28;12(3):326-37. doi: 10.7150/ijbs.15017. eCollection 2016.
7
Developments in miRNA gene signaling pathways in pancreatic cancer.
Future Oncol. 2016 May;12(9):1135-50. doi: 10.2217/fon-2015-0050. Epub 2016 Mar 17.
8
MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers.
Tumour Biol. 2016 Jan;37(1):97-104. doi: 10.1007/s13277-015-4346-6. Epub 2015 Nov 4.
9
MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications.
Cancer Lett. 2010 Jun 1;292(1):8-16. doi: 10.1016/j.canlet.2009.11.010. Epub 2009 Dec 9.
10
Targeting miRNAs for pancreatic cancer therapy.
Curr Pharm Des. 2014;20(33):5279-86. doi: 10.2174/1381612820666140128210443.
引用本文的文献
1
Emerging Tumor Biomarkers in Pancreatic Cancer and Their Clinical Implications.
Curr Issues Mol Biol. 2025 May 10;47(5):347. doi: 10.3390/cimb47050347.
2
Unraveling the therapeutic landscape of miRNAs in pancreatic cancer.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 2. doi: 10.1007/s00210-025-04301-w.
3
Paracrine regulation of pancreatic cancer cell response to chemotherapy by GLI2-collagen I signaling.
J Biol Chem. 2025 May 29;301(7):110311. doi: 10.1016/j.jbc.2025.110311.
4
Molecular Targets for the Diagnosis and Treatment of Pancreatic Cancer.
Int J Mol Sci. 2024 Oct 9;25(19):10843. doi: 10.3390/ijms251910843.
5
MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces.
Int J Mol Sci. 2024 Jul 26;25(15):8191. doi: 10.3390/ijms25158191.
6
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer.
Front Oncol. 2024 Jul 17;14:1427802. doi: 10.3389/fonc.2024.1427802. eCollection 2024.
7
Gut-Liver-Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies.
Biomedicines. 2024 Jun 24;12(7):1398. doi: 10.3390/biomedicines12071398.
8
MicroRNA-409: Molecular functions and clinical applications in cancer.
Biochem Biophys Rep. 2024 May 3;38:101728. doi: 10.1016/j.bbrep.2024.101728. eCollection 2024 Jul.
9
MicroRNAs in Pancreatic Cancer: Advances in Biomarker Discovery and Therapeutic Implications.
Int J Mol Sci. 2024 Mar 31;25(7):3914. doi: 10.3390/ijms25073914.
10
Trials and Tribulations of MicroRNA Therapeutics.
Int J Mol Sci. 2024 Jan 25;25(3):1469. doi: 10.3390/ijms25031469.
本文引用的文献
1
Effect of valproic acid on miRNAs affecting histone deacetylase in a model of anaplastic thyroid cancer.
Mol Biol Rep. 2021 Aug;48(8):6085-6091. doi: 10.1007/s11033-021-06616-2. Epub 2021 Aug 10.
2
Identification of miRNA signatures and their therapeutic potentials in prostate cancer.
Mol Biol Rep. 2021 Jul;48(7):5531-5539. doi: 10.1007/s11033-021-06568-7. Epub 2021 Jul 27.
3
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study.
Biomark Res. 2021 Jul 13;9(1):57. doi: 10.1186/s40364-021-00289-6.
4
Overexpression of Long Noncoding RNA H19 Downregulates miR-140-5p and Activates PI3K/AKT Signaling Pathway to Promote Invasion, Migration and Epithelial-Mesenchymal Transition of Ovarian Cancer Cells.
Biomed Res Int. 2021 Jun 21;2021:6619730. doi: 10.1155/2021/6619730. eCollection 2021.
5
A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.
Int J Mol Sci. 2021 Jun 6;22(11):6121. doi: 10.3390/ijms22116121.
6
miRNA Clusters with Up-Regulated Expression in Colorectal Cancer.
Cancers (Basel). 2021 Jun 14;13(12):2979. doi: 10.3390/cancers13122979.
7
Circ3823 contributes to growth, metastasis and angiogenesis of colorectal cancer: involvement of miR-30c-5p/TCF7 axis.
Mol Cancer. 2021 Jun 25;20(1):93. doi: 10.1186/s12943-021-01372-0.
8
miR-210-3p Promotes Lung Cancer Development and Progression by Modulating USF1 and PCGF3.
Onco Targets Ther. 2021 Jun 9;14:3687-3700. doi: 10.2147/OTT.S288788. eCollection 2021.
9
Anti-oncogenic effects of SOX2 silencing on hepatocellular carcinoma achieved by upregulating miR-222-5p-dependent CYLD via the long noncoding RNA CCAT1.
Aging (Albany NY). 2021 Mar 22;13(8):12207-12223. doi: 10.18632/aging.103797.
10
Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer.
Cancer Prev Res (Phila). 2021 Jul;14(7):729-740. doi: 10.1158/1940-6207.CAPR-20-0303. Epub 2021 Apr 23.
Zotero 插件